{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:06:58Z","timestamp":1788430018767,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International AG","doi-asserted-by":"publisher","award":["IIR-DEU-002540"],"award-info":[{"award-number":["IIR-DEU-002540"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GR 4688\/2\u20131"],"award-info":[{"award-number":["GR 4688\/2\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nicl.2022.103296","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:13:23Z","timestamp":1671538403000},"page":"103296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation"],"prefix":"10.1016","volume":"37","author":[{"given":"Joana","family":"Feldmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimdota","family":"Zizmare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Kr\u00e4geloh-Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Groeschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nicl.2022.103296_b0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10545-007-0635-6","article-title":"Quantification of N-acetylaspartic acid in urine by LC-MS\/MS for the diagnosis of Canavan disease","volume":"30","author":"Al-Dirbashi","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.nicl.2022.103296_b0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/JCNSD.S11861","article-title":"Multi-voxel 1H-MRS in metachromatic leukodystrophy","volume":"5","author":"Assadi","year":"2013","journal-title":"J Cent Nerv Syst Dis"},{"issue":"1","key":"10.1016\/j.nicl.2022.103296_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/awab304","article-title":"Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy","volume":"145","author":"Beerepoot","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2022.103296_b0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fendo.2017.00240","article-title":"N-Acetylaspartate metabolism outside the brain: lipogenesis, histone acetylation, and cancer","volume":"8","author":"Bogner-Strauss","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1\u20132","key":"10.1016\/j.nicl.2022.103296_b0025","first-page":"235","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1\/2 clinical trial","volume":"131","author":"C, i.d.,","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.nicl.2022.103296_b0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acn3.51254","article-title":"Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1\/2 study","volume":"8","author":"C, i.d.,","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2022.103296_b0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jimd.12388","article-title":"Metachromatic leukodystrophy: A single-center longitudinal study of 45 patients","volume":"44","author":"Fumagalli","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10322","key":"10.1016\/j.nicl.2022.103296_b0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nicl.2022.103296_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0030-1253412","article-title":"Metachromatic leukodystrophy\u2013an update","volume":"41","author":"Gieselmann","year":"2010","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.nicl.2022.103296_b0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V","article-title":"Proton NMR chemical shifts and coupling constants for brain metabolites","volume":"13","author":"Govindaraju","year":"2000","journal-title":"NMR Biomed."},{"issue":"5","key":"10.1016\/j.nicl.2022.103296_b0055","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10545-011-9361-1","article-title":"Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course","volume":"34","author":"Groeschel","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"16","key":"10.1016\/j.nicl.2022.103296_b0060","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e31826e9ad2","article-title":"Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy","volume":"79","author":"Groeschel","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nicl.2022.103296_b0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.nicl.2022.103296_b0070","doi-asserted-by":"crossref","first-page":"e0167274","DOI":"10.1371\/journal.pone.0167274","article-title":"Assessing white matter microstructure in brain regions with different myelin architecture using MRI","volume":"11","author":"Groeschel","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nicl.2022.103296_b0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C","article-title":"Leukodystrophy incidence in Germany","volume":"71","author":"Heim","year":"1997","journal-title":"Am. J. Med. Genet."},{"issue":"21","key":"10.1016\/j.nicl.2022.103296_b0080","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1212\/WNL.0b013e3181feb217","article-title":"Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy","volume":"75","author":"i Dali, C.,","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1469-8749.2010.03821.x","article-title":"Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"issue":"9","key":"10.1016\/j.nicl.2022.103296_b0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-8749.2011.04028.x","article-title":"The natural course of gross motor deterioration in metachromatic leukodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nicl.2022.103296_b0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-9-18","article-title":"Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort","volume":"9","author":"Kehrer","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0100","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1212\/WNL.0000000000011047","article-title":"Association of age at onset and first symptoms with disease progression in patients with metachromatic leukodystrophy","volume":"96","author":"Kehrer","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2022.103296_b0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bmt.2012.155","article-title":"Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort","volume":"48","author":"Krageloh-Mann","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"10043","key":"10.1016\/j.nicl.2022.103296_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(16)30450-0","article-title":"Therapies of lysosomal storage disorders targeting the brain","volume":"388","author":"Krageloh-Mann","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF00869766","article-title":"Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo","volume":"241","author":"Kruse","year":"1993","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0120","first-page":"168","article-title":"Identification of neurodegeneration indicators and disease progression in metachromatic leukodystrophy using quantitative NMR-based urinary metabolomics","volume":"63","author":"Laugwitz","year":"2022","journal-title":"JIMD Rep."},{"key":"10.1016\/j.nicl.2022.103296_b0125","article-title":"T2-pseudonormalization and microstructural characterization in advanced stages of late-infantile metachromatic leukodystrophy","author":"Martin","year":"2020","journal-title":"Clin. Neuroradiol."},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.nicl.2022.103296_b0135","doi-asserted-by":"crossref","first-page":"e4257","DOI":"10.1002\/nbm.4257","article-title":"Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations","volume":"34","author":"Near","year":"2021","journal-title":"NMR Biomed."},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0140","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00429-013-0691-7","article-title":"Localisation of N-acetylaspartate in oligodendrocytes\/myelin","volume":"220","author":"Nordengen","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"3","key":"10.1016\/j.nicl.2022.103296_b0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"issue":"W1","key":"10.1016\/j.nicl.2022.103296_b0150","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.nicl.2022.103296_b0155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.2010.06831.x","article-title":"Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair","volume":"114","author":"Piaton","year":"2010","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.nicl.2022.103296_b0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/acn3.420","article-title":"Demyelination load as predictor for disease progression in juvenile metachromatic leukodystrophy","volume":"4","author":"Strolin","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"9","key":"10.1016\/j.nicl.2022.103296_b0165","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.232","article-title":"Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy","volume":"2","author":"Tillema","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.nicl.2022.103296_b0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00415-018-8765-3","article-title":"Diffusion tensor imaging in metachromatic leukodystrophy","volume":"265","author":"van Rappard","year":"2018","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2022.103296_b0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jnnp-2017-316364","article-title":"Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment","volume":"89","author":"van Rappard","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.nicl.2022.103296_b0180","first-page":"585","article-title":"Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T","volume":"26","author":"Wellard","year":"2005","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.nicl.2022.103296_b0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mrm.27742","article-title":"Methodological consensus on clinical proton MRS of the brain: Review and recommendations","volume":"82","author":"Wilson","year":"2019","journal-title":"Magn. Reson. Med."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158222003618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158222003618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:31:31Z","timestamp":1781105491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158222003618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":37,"alternative-id":["S2213158222003618"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2022.103296","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2022.103296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103296"}}